Amgen to acquire Seattle biotech company Rodeo Therapeutics for $55M
Rodeo Therapeutics CEO Thong Le. (Accelerator Life Science Partners Photo) The news: Pharmaceutical giant Amgen
Read the full article at contacted.org...
Found and curated by
Rodeo Therapeutics CEO Thong Le. (Accelerator Life Science Partners Photo) The news: Pharmaceutical giant Amgen
Read the full article at contacted.org...
Found and curated by
Comments
Post a Comment